At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Evaluation of the long-term complete remission rate (> 12 months)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal Tumors
In Brief
An observational study evaluating Evaluation of the long-term complete remission rate (> 12 months) for Superficial Colorectal Tumors. Completed, enrolled 100 participants across 1 site.
Detailed Summary
To evaluate the long-term complete remission rate (\> 12 months) after endoscopic treatment of early neoplastic colorectal lesions.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSuperficial Colorectal Tumors
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
Primary CompletionDec 2016
Study CompletionNov 2017
First PostedMar 2018
TodayJul 2026
First PostedMar 20, 2018
Enrollment StartJan 1, 2012
Primary CompletionDec 31, 2016
Study CompletionNov 2, 2017
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 8.3 years ago
Interventions
Evaluation of the long-term complete remission rate (> 12 months)other
Evaluation of the long-term complete remission rate (\> 12 months)